Search Results - "Ruottinen, Hanna"

Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms by Makkonen, Tanja, Ruottinen, Hanna, Puhto, Riitta, Helminen, Mika, Palmio, Johanna

“…Background The symptoms and their progression in amyotrophic lateral sclerosis (ALS) are typically studied after the diagnosis has been confirmed. However,…”
Get full text

Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis by Makkonen, Tanja, Korpijaakko-Huuhka, Anna-Maija, Ruottinen, Hanna, Puhto, Riitta, Hollo, Kirsi, Ylinen, Aarne, Palmio, Johanna

“…Abstract The aim of this study was to explore the cranial nerve symptoms, speech disorders and communicative effectiveness of Finnish patients with diagnosed…”
Get full text

Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study by Nurmi, Elina, Ruottinen, Hanna M., Bergman, Jörgen, Haaparanta, Merja, Solin, Olof, Sonninen, Pirkko, Rinne, Juha O.

“…The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[18F]fluoro‐L‐dopa (FDOPA) positron emission tomography…”
Get full text

Imaging Brain Iron and Diffusion Patterns by Rossi, Maija Elina, PhD, Ruottinen, Hanna, MD, PhD, Saunamäki, Tiia, MD, PhD, Elovaara, Irina, MD, PhD, Dastidar, Prasun, MD, PhD

“…Rationale and Objectives The aim of this study was to examine changes of brain iron content and diffusion patterns longitudinally in early-stage Parkinson's…”
Get full text

Upregulation of Putaminal Dopamine D2 Receptors in Early Parkinson's Disease: A Comparative PET Study with [11C]Raclopride and [11C]N-Methylspiperone by Kaasinen, Valtteri, Ruottinen, Hanna M, Nagren, Kjell, Lehikoinen, Pertti, Oikonen, Vesa, Rinne, Juha O

“…Dopamine D2 receptor function was assessed in a PET study with 2 dopamine D2 receptor PET ligands, [11C]raclopride (RAC) and [11C]N-methylspiperone (NMSP), in…”
Get full text

Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages by Rossi, Maija Elina, Ruottinen, Hanna, Saunamäki, Tiia, Elovaara, Irina, Dastidar, Prasun

“…The aim of this study was to examine changes of brain iron content and diffusion patterns longitudinally in early-stage Parkinson's disease (PD) patients using…”
Get full text

Clinical MRI for iron detection in Parkinson's disease by Rossi, Maija, Ruottinen, Hanna, Soimakallio, Seppo, Elovaara, Irina, Dastidar, Prasun

“…Abstract We studied nonheme iron in Parkinson's disease (PD) using clinically available MRI in 36 patients and 21 healthy volunteers. The subjects underwent…”
Get full text

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program by Odin, P, Ray Chaudhuri, K, Slevin, J.T, Volkmann, J, Dietrichs, E, Martinez-Martin, P, Krauss, J.K, Henriksen, T, Katzenschlager, R, Antonini, A, Rascol, O, Poewe, W

“…Abstract Navigate PD was an educational program established to supplement existing guidelines and provide recommendations on the management of Parkinson's…”
Get full text

[18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease by O. Rinne, Juha, Nurmi, Elina, Ruottinen, Hanna M., Bergman, Jörgen, Eskola, Olli, Solin, Olof

“…The aim of this study was to compare two PET ligands, 6‐[18F]fluoro‐L‐dopa ([18F]FDOPA) and 18F‐labeled CFT, 2β‐carbomethoxy‐3β‐(4‐[18F]‐fluorophenyl)tropane…”
Get full text

Brain Iron Deposition and Sequence Characteristics in Parkinsonism: Comparison of SWI, T2 Maps, T2-Weighted-, and FLAIR-SPACE by Rossi, Maija, Ruottinen, Hanna, Elovaara, Irina, Ryymin, Pertti, Soimakallio, Seppo, Eskola, Hannu, Dastidar, Prasun

“…OBJECTIVES:To compare quantitatively T2- and T2*-based magnetic resonance imaging sequences in patients with symptoms of Parkinson disease and to evaluate the…”
Get full text

Variation in communication strategies in amyotrophic lateral sclerosis during a two-year follow-up by Makkonen, Tanja, Ruottinen, Hanna, Korpijaakko-Huuhka, Anna-Maija, Palmio, Johanna

Get full text

MR image texture in Parkinson's disease: a longitudinal study by Sikiö, Minna, Holli-Helenius, Kirsi K, Harrison, Lara C V, Ryymin, Pertti, Ruottinen, Hanna, Saunamäki, Tiia, Eskola, Hannu J, Elovaara, Irina, Dastidar, Prasun

“…Few of the structural changes caused by Parkinson's disease (PD) are visible in magnetic resonance imaging (MRI) with visual inspection but there is a need for…”
Get more information

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome by RUOTTINEN, H. M, PARTINEN, M, HUBLIN, C, BERGMAN, J, HAAPARANTA, M, SOLIN, O, RINNE, J. O

“…The authors investigated nine drug-naive patients with periodic limb movement disorder and restless legs syndrome (PLMD-RLS) and 27 healthy controls with PET…”
Get full text

Parkinson’s Disease by Sikiö, Minna, Holli, Kirsi K., Harrison, Lara C.V., Ruottinen, Hanna, Rossi, Maija, Helminen, Mika T., Ryymin, Pertti, Paalavuo, Raija, Soimakallio, Seppo, Eskola, Hannu J., Elovaara, Irina, Dastidar, Prasun

Get full text

Parkinson's disease: interhemispheric textural differences in MR images by Sikiö, Minna, Holli, Kirsi K, Harrison, Lara C V, Ruottinen, Hanna, Rossi, Maija, Helminen, Mika T, Ryymin, Pertti, Paalavuo, Raija, Soimakallio, Seppo, Eskola, Hannu J, Elovaara, Irina, Dastidar, Prasun

“…Early-stage diagnosis of Parkinson's disease (PD) is essential in making decisions related to treatment and prognosis. However, there is no specific diagnostic…”
Get full text

Parkinson’s Disease by Sikiö, Minna, Holli, Kirsi K., Harrison, Lara C.V., Ruottinen, Hanna, Rossi, Maija, Helminen, Mika T., Ryymin, Pertti, Paalavuo, Raija, Soimakallio, Seppo, Eskola, Hannu J., Elovaara, Irina, Dastidar, Prasun

“…Early-stage diagnosis of Parkinson’s disease (PD) is essential in making decisions related to treatment and prognosis. However, there is no specific diagnostic…”
Get full text

Parkinson’s Disease by Sikiö, Minna, MSc, Holli, Kirsi K., MSc, Harrison, Lara C.V., MSc, MD, Ruottinen, Hanna, MD, PhD, Rossi, Maija, MSc, Helminen, Mika T., MSc, Ryymin, Pertti, PhLic, Paalavuo, Raija, BHc, Soimakallio, Seppo, MD, PhD, Eskola, Hannu J., PhD, Elovaara, Irina, MD, PhD, Dastidar, Prasun, MD, PhD

“…Rationale and Objectives Early-stage diagnosis of Parkinson’s disease (PD) is essential in making decisions related to treatment and prognosis. However, there…”
Get full text

Usefulness of a dopamine transporter PET ligand [18F]β-CFT in assessing disability in Parkinson's disease by Rinne, Juha O, Ruottinen, Hanna, Bergman, Jörgen, Haaparanta, Merja, Sonninen, Pirkko, Solin, Olof

“…OBJECTIVES The usefulness of a novel dopamine transporter PET ligand, [18F]β-CFT in assessing disability in Parkinson's disease was studied. METHODS Twenty…”
Get full text

Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study by Rinne, J O, Portin, R, Ruottinen, H, Nurmi, E, Bergman, J, Haaparanta, M, Solin, O

“…To investigate the role of the brain dopaminergic system in cognitive impairment in patients with Parkinson disease (PD). We studied 28 patients with PD and 16…”
Get more information

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [ 11C]raclopride by Rinne, Juha O., Laihinen, Arto, Ruottinen, Hanna, Ruotsalainen, Ulla, Någren, Kjell, Lehikoinen, Pertti, Oikonen, Vesa, Rinne, U.K.

“…Striatal dopamine D2 receptors were studied, using positron emission tomography (PET), in 10 patients with early Parkinson's disease without any…”
Get full text